ADCY4 inhibits cAMP-induced growth of breast cancer by inactivating FAK/AKT and ERK signaling but is frequently silenced by DNA methylation
Abstract Local increases in cyclic adenosine monophosphate (cAMP) caused by specific adenylyl cyclases (ACs) can selectively modulate related proteins. AC-selective drugs have an advantage in side effect control, and the specific AC may finally be considered as a therapeutic target. We show that ade...
Saved in:
| Main Authors: | Guangrui Pan, Mingquan Huang, Shaozhi Fu, Yu Wang, Lijia He, Bin Wu, Jinping Yang, Sheng Lin, Yu Fan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-06294-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of ADCY1 in Regulating the Sensitivity of Platinum-Based Chemotherapy in NSCLC
by: Ting Zou, et al.
Published: (2024-08-01) -
A Rare Case of Monogenic Obesity Due to a Novel Variant in the ADCY3 Gene: Challenges in Follow-up and Treatment
by: Bahar Özcabı, et al.
Published: (2025-09-01) -
Structural basis of human ABCC4 recognition of cAMP and ligand recognition flexibility
by: Xuepeng Wen, et al.
Published: (2025-03-01) -
FAK inhibition disrupts tumor growth, apoptosis, and transcriptional regulation in GI-NETs
by: Lara Toffoli, et al.
Published: (2025-08-01) -
Metformin inhibits melanin synthesis and melanosome transfer through the cAMP pathway
by: Xing Liu, et al.
Published: (2025-04-01)